Pricing Log in Create free account

Innate Pharma S.A. Sponsored ADR (IPHA) vs Sutro Biopharma, Inc. (STRO)

Innate Pharma S.A. Sponsored ADR and Sutro Biopharma, Inc. are both Biotechnology companies. Innate Pharma S.A. Sponsored ADR and Sutro Biopharma, Inc. are of similar size ($160.9M and $159.5M). Innate Pharma S.A. Sponsored ADR grew revenue faster over the last twelve months: −4.17% against −56.3%. Innate Pharma S.A. Sponsored ADR has the higher net margin (−99.7% vs −395.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Innate Pharma S.A. Sponsored ADR leads on 9 and Sutro Biopharma, Inc. on 6.

Valuation

Metric IPHA STRO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 3.49 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.12 0.06 9.02
Earnings yield (81.01%) (180.08%) (32.88%)
Free cash flow yield 0.00% (91.34%) (23.13%)

Profitability

Metric IPHA STRO Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (319.57%) 0.00%
Net margin (99.70%) (395.25%) 0.00%
Free cash flow margin 0.00% (318.63%) 0.00%
Return on equity 0.00% 266.76% (51.96%)
Return on assets 0.00% (79.08%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IPHA STRO Biotechnology median
Revenue growth (TTM) (4.17%) (56.25%) 6.76%
EPS growth (last fiscal year) 6.06% 24.02% 29.88%
Revenue growth, 5-year CAGR (33.86%) 19.12% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IPHA STRO Biotechnology median
Debt to equity (0.50) 0.00 0.00
Current ratio 0.60 3.32 4.97
Net debt to EBITDA 0.22 0.92 1.01

Dividend

Metric IPHA STRO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IPHA STRO Biotechnology median
Market cap 160.85m 159.51m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack